Ashurst advises Agilitas on buyout of Frontier

Global law firm Ashurst has advised long-standing client Agilitas Private Equity on the buyout of Frontier Medical Group (‘Frontier’), a leading medical device manufacturer that focuses on skin and wound care.

Frontier has over 24 years’ experience designing and manufacturing clinically proven, high-quality and cost-effective products that are used in the prevention and treatment of pressure ulcers. Frontier supplies both acute and homecare markets in the UK and internationally and maintains its market-leading position through a dedicated in-house Research and Development function.

Frontier operates internationally via its headquarters and manufacturing facility in South Wales, as well as its offices in Berlin and Buffalo, NY. It has direct sales teams in the UK, Germany and the US, and benefits from a network of distributors across 18 countries.

The Ashurst team was led by corporate partners David Carter and Braeden Donnelly, senior associates Francesca Downes, Sara Hamzawi and Shaz Ali and associate Becky Eaton. Partner Nick Pawson and senior associate Sam Tetlow advised on banking aspects. Tax advice was provided by partner Alexander Cox and associate Shayaan Zaraq Bari. Pensions counsel John Gordon, IP counsel Don McCombie and digital economy associate Satya Doraisamy also advised. Real estate advice was provided by senior associates James Nierinck and Julie Connolly and associates Joanna Fox and Charlotte Coyle. Employment advice was provided by partner Crowley Woodford and associate David Pemberton, with incentives advice from senior associate Rebecca Servian.

/Public Release. This material comes from the originating organization and may be of a point-in-time nature, edited for clarity, style and length.